Abstract : The osteoclast is a multinucleated giant cell differentiated from monocyte macrophages that has an important role in bone resorption. Several studies have reported a relationship between tea consumption and decreased risk of bone fracture. Matrix metalloproteinases MMPs play an important role in the degeneration of bone and cartilage matrix. Regulation of osteoclast activity is essential in the treatment of bone disease. Moreover, MMPs are associated with osteoclast formation and differentiation. We have reported previously that -epigallocatechin-3-gallate EGCG inhibits MMP-2 and MMP-9 expression and activity. However, the effects of EGCG on osteoclasts and other MMPs are not clear. Therefore, in the present study we examined whether EGCG affects MMP expression, as well as osteoclast formation, differentiation and activity, in vitro. We used bone marrow cells from the femur and tibial bones of male ddY mice. Bone marrow cells were cultured in the presence of 1 100 M EGCG for 6 or 8 days. EGCG decreased the number of mature osteoclasts, as determined by tartrateresistant acid phosphatase staining. Concentrations as low as 1 M EGCG clearly inhibited the differentiation of osteoclasts from bone marrow cells. EGCG also inhibited the number of osteoclasts with an actin-ring, as determined by rhodamine phalloidin staining, as well as osteoclast activity, as determined by the pit formation assay. Furthermore, EGCG concentration-dependently decreased MMP-9 and membrane type 1-MMP mRNA expression in mouse osteoclasts. However, EGCG had no changing on mRNA levels of tissue inhibitor of metalloprotease TIMP -1 and TIMP-3. Together, the results suggest that EGCG may be a suitable agent or lead compound for the development of treatments for bone resorption diseases associated with MMPs.
Introduction
It has been proposed that tea consumption can activate mechanisms that modulate and potentially slow the progression of age-related diseases, such as cardiovascular disease, cancer, obesity, Alzheimer s disease and osteoporosis 1, 2 . Several recent studies have reported that tea consumption has a bene cial effect on orthopedic diseases. For example, tea consumption reportedly helps protect against hip fractures 3 , and bone mineral density measurements are higher in older women who drink tea compared with those who do not 4 . Green, black, and Oolong teas are made from the leaves of Camellia sinensis. Catechins are important components of green tea and include -epigallocatechin-3-gallate EGCG , -epigallocatechin EGC , -epicatechin-3-gallate ECG , and -epicatechin EC 5 . EGCG is the most abundant polyphenol in green tea. It is known that catechins, particularly EGCG, have health bene ts. For example, EGCG has been reported to suppress osteoclast differentiation and ameliorate rheumatoid arthritis RA in a mouse model of the disease 6 . Osteoclasts, which are essential in bone homeostasis, play a key role in the development of osteoporosis, in ammatory arthritis, and RA. Progressive bone destruction in RA involves the abnormal activation of osteoclasts. This activation is due to interactions with synovial broblasts and T helper cells that express receptor activator of nuclear factor-B ligand RANKL 7 . To treat bone-associated diseases, it is important that osteoclast activity be inhibited.
There are several reports of the effects of EGCG on mouse osteoclasts 6, 8 . In a previous study, we demonstrated that thea avin-3, 3 -digallate TFDG and EGCG, at concentrations of 10 or 100 M, inhibit osteoclast formation and / or differentiation in rat osteoclast precursor cells, as well as in mature osteoclasts 9 . In addition, TFDG and EGCG suppress matrix metalloproteinase MMP -2 and MMP-9 enzyme activity, and MMP-9 mRNA expression in osteoclast precursor cells 9 . Activated osteoclasts exhibit polarized cytoskeletal structures known as actin rings, and the formation of these rings is important for bone resorption 10 . TFDG and EGCG may suppress osteoclast differentiation by inhibiting the formation of cytoskeletal actin rings in mature osteoclasts as a result of the suppression of MMPs 9 .
MMPs comprise a family of zinc-dependent endopeptidases and include collagenases MMP-1, -8, -13 and -18 , gelatinases MMP-2 and -9 , stromelysins MMP-3 and -10 , and membranetype MT1-MMP ; MMP-14 endopeptidases 11 . These MMPs can degrade the organic components of connective tissue matrices 12 . MMPs play a crucial role in tissue remodeling and in the destruction of bone in arthritic joints because they are able to degrade a wide variety of extracellular matrix components 13 . In particular, MMP-9 is essential for initiating the osteoclastic resorption process by removal of the collagenous layer from the bone surface prior to demineralization 14 . Osteoclasts produce MMPs ; furthermore, MMP-9 expression in osteoclasts is markedly higher than in other cell types 15 . MMPs are secreted as proenzymes by many cell types. MMP activity is regulated by activation of precursor zymogens and is inhibited by endogenous inhibitors and tissue inhibitors of metalloproteinases TIMPs . TIMPs tightly control MMP activity at a 1 : 1 ratio 12 . TIMP-1 inhibits all known active forms of MMPs, as well as proMMP-9 11 .
However, the relationship between EGCG and many MMPs and TIMPs in osteoclasts remains somewhat unclear.
In the present study we examined the ability of EGCG to suppress the expression, differentiation, maturation, and activity of individual MMPs and TIMPs in mouse osteoclasts obtained from bone marrow cells.
Materials and methods

Animals and reagents
In the present study we used 5-8-week-old male ddY mice Sankyo Labo Service Corporation, Tokyo, Japan . All experiments were conducted in accordance with the Guiding Principles for the Care and Use of Laboratory Animals of The Japanese Pharmacological Society and were approved by the Showa University Animal Care and Use Committee certificate no. 13041 . EGCG was purchased from Wako Pure Chemical Industries Osaka, Japan . Macrophage colony-stimulating factor M-CSF / CSF-1 and RANKL were obtained from Peprotech Rocky Hill, NJ, USA .
Osteoclast formation assay
Bone marrow cells were obtained from the femur and tibia of mice. The bone marrow cells were cultured to a high density 1.0 10 5 cells / well in a 96-well plate for 6 days in medium containing 15 serum, 25 ng / mL M-CSF, and 100 ng / mL RANKL at 37 in a humidi ed atmosphere of 5 CO 2 . The medium was changed on Days 1 and 3. The cells were assigned to one of five experimental groups : i a negative control group without M-CSF and RANKL ; ii a control group medium alone ; and iii-v cells treated with 1, 10 or 100 M EGCG, respectively. EGCG was added to the appropriate cultures each day for 6 days 12 .
Bone marrow cells 1.0 10 6 cells / well were also cultured in a six-well plate for 8 days in the same medium and under the same conditions as described above. The medium was changed on Days 2, 4 and 7. In this series of experiments, cells were assigned to one of four groups, namely a control group medium alone and cells treated with 10, 50 or 100 M EGCG. EGCG was added to the appropriate cultures on each day for 8 days.
F-Actin and tartrate-resistant acid phosphatase staining
At the end of the culture period, cells were xed with 4 paraformaldehyde for F-actin staining and then permeated with 0.1 Triton X-100 in phosphate-buffered saline PBS for 5 min. F-Actin was stained with 0.3 mM rhodamine-conjugated phalloidin. The ring-forming F-actin bands were detected under a Zeiss Axiophot fluorescent microscope Carl Zeiss, Jena, Germany . Subsequently, cells were stained for tartrate resistant acid phosphatase TRAP using a nal concentration of 50 mM tartrate. TRAP-positive multinucleated cells with more than three nuclei were considered to be osteoclasts and were counted under a light microscope.
Pit formation assay
Bone marrow cells 1.0 10 6 cells / well were cultured in a Corning Osteo Assay Surface Polystyrene 1 8 Stripwell microplate Corning, Corning, NY, USA for 8 days in medium containing 15 serum, 25 ng / mL M-CSF, and 100 ng / mL RANKL at 37 in a humidi ed atmosphere of 5 CO 2 . The medium was changed on Days 2, 4, and 7. Cells were assigned to one of three groups, namely a control group medium alone and groups cultured in the presence of 10 or 50 M EGCG. EGCG was added to the appropriate cultures each day for 8 days. Von Kossa staining was used to analyze the microplate surface for pit formation. Brie y, the medium was aspirated from the wells after 8 days and the wells were washed with distilled water. The wells were then incubated with 1 M ammonia solution overnight. After overnight incubation, the wells were washed with distilled water before being stained with 5 silver nitrate for 60 min at room temperature under a bright light. To stop the development of silver nitrate, cells were washed with water and treated with a 5 solution of sodium thiosulfate. Following another water wash and air drying, nodules were visualized as dark-stained patches under a light microscope. The resorbed area was measured using Adobe Photoshop Elements 9 Adobe Systems, San Jose, CA, USA .
RNA isolation and quantitative real-time reverse transcription-polymerase chain reaction
Quantitative polymerase chain reaction PCR was used to quantify mRNA levels of MMP-9, MMP-13, MT1-MMP, TIMP-1 and TIMP-3 in osteoclasts after 8 days culture and / or in bone marrow cells after 2 days culture . Cells 1.0 10 6 cells / well were harvested and total RNA was extracted with NucleoSpin RNA II MACHEREY-NAGEL, Duren, Germany . Total RNA was reverse transcribed using PrimeScript RT Master Mix TaKaRa Bio, Shiga, Japan . The cDNA was amplified using primers designed with ProbeFiber software Roche Applied Science, Mannheim, Germany . Table 1 details the primers used, the Roche Universal ProbeLibrary Probe numbers, and accession numbers. Ampli cation was performed with a LightCycler 17 .
Statistical analysis
Data were analyzed using the Bonferroni test following one-way analysis of variance ANO-VA . All data are expressed as the mean SEM. P 0.05 was considered signi cant.
Results
Effect of tea polyphenols on osteoclast formation
To examine the effect of EGCG on osteoclast formation, bone marrow cell cultures were treated with EGCG at concentrations of 1, 10, and 100 M for 6 days Fig. 1D , E . There were more TRAP-positive multinucleated osteoclasts in the control group 
Effect of EGCG on F-actin bands of bone marrow cells
After 8 days culture in medium containing RANKL and M-CSF control culture , numerous large multinucleated osteoclasts were detected. In contrast, very few large multinucleated osteoclasts were observed after cell culture in the presence of EGCG. As shown in Fig. 2 , EGCG inhibited the formation of TRAP-positive multinuclear osteoclasts from mature osteoclasts. Furthermore, ring-forming F-actin bands were evident around TRAP-positive multinuclear osteoclasts in control cultures Fig. 2A , E . However, there was a decrease in the ring-forming F-actin bands in the positive control and in 10 M EGCG to 47.4 and 38.7 as compared with the number of TRAP-positive multinuclear osteoclasts, respectively. Fig. 2I , J . Figure 2F shows incomplete ring formation of the F-actin bands in the 10 M EGCG-treated group. Exposure of cells to EGCG dose-dependently reduced the number of mature osteoclasts, as characterized by actin rings Fig. 2F -H, J .
Effects of tea polyphenols on osteoclast activity
To examine the effect of EGCG on osteoclast activity, bone marrow cells were cultured in the presence of 10 and 50 M EGCG for 8 days Fig. 3A -C . Treatment with EGCG dosedependently reduced osteoclast activity Fig. 3D . Figure 4 shows the expression of MMP and TIMP mRNA following treatment with 10, 50, and 100 M EGCG for 8 days, normalized against mRNA expression in the control group at 5 cells / well were cultured in a six-well plate for 8 days. The low condensed bone marrow cells become the mature osteoclasts at 8 days of culture. Cells were stained with rhodamine-conjugated phalloidin E-H , after which osteoclasts were identified by tartrate-resistant acid phosphatase TRAP staining A-D . Red arrows A, B indicate TRAP-positive multinucleated osteoclasts; the white arrow E shows clear F-actin rings, the yellow arrow F indicates unclear F-actin rings. I TRAP-positive multinucleated cells characterized by more than three nuclei were determined to be osteoclasts and counted. J Osteoclasts exhibiting clear F-actin rings white arrow were determined to be activated osteoclasts and were counted. Cont, control. Data are the mean SEM n 6 in each group . P 0.05, P 0.01 compared with control ; P 0.01 compared with 10 M EGCG.
Effects of EGCG on mRNA levels of MMPs and TIMPs in osteoclasts
8 days set at 100 . EGCG treatment dose-dependently reduced MMP-9 mRNA levels Fig.  4A . MMP-9 mRNA levels of cultured bone marrow cells after 2 days were signi cantly different compared with the 8 days control P 0.01 and 100 M EGCG-treated group P 0.010 .
There was no signi cant change in MMP-13 mRNA levels from Day 2 to Day 8 of culture in either the control or 10 M EGCG-treated group. In contrast, after 8 days culture, 50 and 100 M EGCG suppressed MMP-13 mRNA expression, although the suppression in the presence of 50 M EGCG was greater Fig. 4B . Exposure of cells to 10, 50, and 100 M EGCG for 8 days dose-dependently reduced MT1-MMP mRNA levels Fig. 4C . On Day 2 of in the control culture, TIMP-1 mRNA levels were significantly higher in the control group compared with the 10, 50, and 100 M EGCG-treated groups P 0.05, P 0.01, and P 0.01, respectively . However, there were no signi cant changes in TIMP-1 mRNA expression from Day 2 to Day 8 P 0.10, Fig. 4D . As indicated in Fig. 4E , there were no signi cant differences among the control and EGCG-treated groups after 8 days in culture.
Discussion
We have demonstrated in the present study that 1 M EGCG : i inhibits osteoclast forma- tion and / or differentiation of mouse bone marrow cells ; ii inhibits osteoclast activity ; and iii suppresses MMP-9, MMP-13, and MT1-MMP mRNA expression in osteoclasts. EGCG inhibited all the processes associated with MMPs and TIMPs involved in the maturation of osteoclasts from bone marrow cells.
Several cohort studies in Western countries have indicated that tea consumption may have osteoporosis-preventive effects 3, 4 . In a case-control study of 632 Japanese women aged 60 years or older, green tea intake was shown to increase bone density 18 . The blood plasma concentra- on human health. Some reports focused on the bene ts of benifuuki green tea, which contains O-methylated catechin. Because the ingestion of benifuuki tea results in higher blood concentrations of EGCG, it may have a more bene cial effect than other green teas 21 .
MMPs are enzymes responsible for the degradation of collagen brils. Evidence indicates that MMPs play a critical role in osteoclastic bone resorption, and that MMPs facilitate the migration of osteoclasts to the bone surface via the extracellular matrix 22 . Ishibashi et al reported that MMP-9 is expressed in osteoclasts at very high levels 23 . In the present study, we demonstrated that MMP-9 mRNA expression in osteoclasts increased 2.93-fold compared with bone marrow cells after 2 days of culture Fig. 4A . EGCG may inhibit MMP-9 mRNA expression in osteoclasts by one of two methods. First, EGCG may inhibit the development of bone marrow cells osteoclast precursor cells to osteoclasts. It has been reported that inhibition of MMP-9 suppresses preosteoclast migration 24 , and EGCG has been shown to directly inhibit MMP-9 activity 9 . EGCG may inhibit MMP-9 expression and activity, which, in turn, inhibits osteoclast precursor cell migration, ultimately resulting in suppression of the formation of multinucleated osteoclasts. Consequently, EGCG suppression of MMP-9 mRNA expression reduces the number of multinucleated osteoclasts. In the present study, we demonstrated that EGCG up to a concentration of 100 M was not toxic to bone marrow cells, because the number of bone marrow cells and / or osteoclast precursor cells following treatment with 100 M EGCG was higher than that in the Day 3 control and in the negative control without M-CSF and RANKL ; Fig. 1A , B, D . Second, EGCG may directly suppress MMP-9 mRNA expression. MMP-9 mRNA expression following treatment with 100 M EGCG was lower than that in the Day 2 control culture. TIMPs tightly control MMP activity in a 1 : 1 ratio 12 . TIMP-1 inhibits all known active forms of MMPs, as well as proMMP-9 11 . Thus, the balance between MMP-9 and TIMP-1 is important for approximating absolute MMP-9 activity 15 . TIMP-3 inhibits all known active forms of MMPs and some of the members of the ADAM a disintegrin and metalloproteinase family 25, 26 . In the present study, TIMP-1 and TIMP-3 mRNA expression in osteoclasts did not change with EGCG treatment, but there was a decrease in MMP-9 mRNA expression. Thus, dose-dependent decreases in MMP-9 activity were observed following EGCG treatment. MMP-13 is more active against type II collagen than other MMPs 27 , and is obligatory for the migration of preosteoclasts 24 . Without the migration of preosteoclasts, multinucleated osteoclasts do not form. Of the TIMPs, TIMP-3 is the most effective inhibitor of MMP-13 activity, and it can also inhibit the activity of MMP-3, MMP-9, and ADAM-17 25, 26 . In the present study, there was no change in the mRNA expression of TIMP-1 and TIMP-3 in osteoclasts after EGCG treatment, but there was a decrease in MMP-13 mRNA expression following 50 M EGCG treatment. MT1-MMP associates with MMP-2 and TIMP-2 at the cell surface and regulates MMP-2 activation 11 , and MT1-MMP is necessary for bone marrow cell fusion during osteoclast and giant cell formation in vitro and in vivo 28 . However, these functions of MT1-MMP do not depend on the catalytic activity of MT1-MMP or on the downstream activation of proMMP-2 28 . MT1-MMP participates in bone marrow cell fusion by regulating Rac1 signaling 28 .
Regulation of osteoclast differentiation may be an important strategy in the treatment of bone resorption and osteoporosis. The present study demonstrated that at concentrations as low as 1 M, EGCG can suppress differentiation in mouse osteoclasts. In addition, EGCG regulates MMPs and TIMPs mRNA expression in mouse osteoclasts. Thus, the results of the present study suggest that the intake of green tea, such as benifuuki green tea, may be effective in preventing osteoporosis.
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